TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner Advancing felzartamab – a CD38-directed antibody with potential broad applicability...
Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific
With a strong track record across APAC, Francis Wan's appointment marks a powerful acceleration of Medison's growth in the region ZUG, Switzerland, Oct. 23, 2025 /PRNewswire/ -- Medison, the creator of a first-of-its-kind unified global...